Intensive glucose therapy and clinical implications of recent data: a consensus statement from the Global Task Force on Glycaemic Control.

Akalin, S; Berntorp, K; Ceriello, A; Das, A K; Kilpatrick, E S; Koblik, T; Munichoodappa, C S; Pan, C Y; Rosenthall, W; Shestakova, M; Wolnik, B; Woo, V; Yang, W Y; Yilmaz, M T

Akalin, S; Berntorp, K; Ceriello, A; Das, A K; Kilpatrick, E S; Koblik, T; Munichoodappa, C S; Pan, C Y; Rosenthall, W; Shestakova, M; Wolnik, B; Woo, V; Yang, W Y; Yilmaz, M T.

Akalin S; Department of Internal Medicine: Endocrinology and Metabolism, Marmara University, Istanbul, Turkey.

Int J Clin Pract ; 63(10): 1421-5, 2009 Oct.

Article en En | MEDLINE | ID: mdl-19769698

Asunto(s)

Diabetes Mellitus Tipo 2/tratamiento farmacológico; Glucosa/uso terapéutico; Hipoglucemiantes/uso terapéutico; Glucemia/metabolismo; Angiopatías Diabéticas/prevención & control; Humanos; Hiperglucemia/prevención & control; Hipoglucemia/prevención & control

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Glucosa / Hipoglucemiantes Tipo de estudio: Clinical_trials / Guideline Límite: Humans Idioma: En Año: 2009 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google